Kawasaki N, Tomita M, Yamashita-Kashima Y, Yoshimura Y, et al. Efficacy of retreatment with polatuzumab vedotin in combination with rituximab in polatuzumab vedotin-resistant DLBCL models. Leuk Lymphoma 2023;64:1938-1948.
PMID: 37548343